VEGFA and hepatocellular carcinoma: A cohort study in Turkish showed that HCC patients with low levels of serum VEGF-A (<100 pg/mL) had a higher overall survival (OS) rate compared to patients with high levels of serum VEGF-A (≥100 pg/mL), indicating as an independent predictor for OS in HCC patients (103).